Simultaneous abuse of Concerta, a central nervous system stimulant, and alcohol, a depressant substance, can have numerous effects on the body. Unbeknownst to many users, each substance can effectively increase the dangers of the other. Substance abuse treatment could make a life-saving difference for someone concurrently abusing these drugs.
The Problem of Alcohol and Concerta Abuse
Concerta (generic name: methylphenidate) is a long-acting, extended release stimulant prescription medication used to alleviate symptoms of Attention Deficit Hyperactivity Disorder (ADHD).
It works by effectively increasing the amount of dopamine, a chemical involved in nerve cell signaling and communication, being used by areas of the brain relating to attention and self-regulation.
When used as prescribed, Concerta can lead to:
- Improved attention.
- Decreased distractibility.
- Increased level of interest.
Despite its effectiveness when appropriately prescribed and taken, the drug has since been adopted for recreational use. As with all stimulants, Concerta has a high potential for abuse. Due to its “party drug” reputation and the high numbers of ADHD diagnoses and accompanying Concerta prescriptions (resulting in it being relatively easy to obtain), the potential for co-abuse with alcohol is also very high.
Signs and Symptoms
Concurrent use of Concerta and alcohol can result in dangerous situations wherein users experience both the stimulant and depressant effects of each respective substance, in addition to a number of other effects brought on by the combination of the two.
Concerta Abuse Signs
- Decreased appetite.
- Increased blood pressure and heart rate.
- Stroke or heart attack in adults.
- New or increased psychiatric problems.
Alcohol Abuse Signs
- Nausea and vomiting.
- Lethargy and drowsiness.
- Disrupted sleep patterns.
- Temporary loss of consciousness.
- Brain damage (specifically to areas related to muscle coordination).
- Liver disease.
Taking these drugs together can producefrightening symptoms that should be taken seriously.
- Agitation / irritability.
- Profound decrease in muscle coordination.
- Severe nausea / uncontrolled vomiting.
- Severe headache.
- Dizziness / fainting.
- Markedly impaired concentration and other areas of cognition.
The prescribed use of Concerta in patients of legal drinking age has increased with the recognition that ADHD tends to persist into adulthood, leading to an entire population of users who may not even realize the potential danger of combining these two substances (Biederman & Spencer, 2002).
If you are concerned about the potentially dangerous health effects of mixing Concerta and alcohol for yourself or a loved one, please call us at 1-888-744-0069 for help finding the right treatment program.
Effects Alcohol and Concerta
As mentioned, both Concerta and alcohol have specific effects when used alone, and when used together the dangers increase.
When taken concurrently, users report:
- An increase in euphoric feelings, more than either drug on its own.
- Decreased perception of drunkenness.
- Increased body movement and restlessness, though the combination of these drugs has been shown to significantly reduce muscle coordination.
When ingested together, even at low doses, the drugs have a notable effect on each other – the alcohol serves to increase the amount of active Concerta available in the central nervous system (Griffin et al, 2013).
Because Concerta is a stimulant and alcohol a depressant, they have mostly opposing effects. This can lead to the increased potential for overuse of both substances due to the counteracting sensations.
Alcohol will continue to have an effect on the body and brain despite the subjective sense of sobriety, which can subsequently lead to excessive drinking and alcohol poisoning.
Due to their addicting qualities, especially when used together, long-term effects of co-use encompass all the risks of each drug alone, with an even higher potential for brain damage due to compounding effects.
Alcohol and Concerta Abuse Treatment
Treatment for co-abuse of Concerta and alcohol will vary based on the needs and age of the individual. The patient will have an initial assessment by an addiction treatment professional and will typically go through a period of supervised detoxification.
It is vital that an individual seeking help with concurrent Concerta and alcohol abuse receive professional assistance and supervision, as detox from alcohol can have severe symptoms that can sometimes be life-threatening. Many inpatient treatment centers offer monitored withdrawal and detox as an early part of the treatment process.
Multiple treatment options are available to address the root of the addiction and find effective ways to cope with the stress of recovery.
Residential treatment offers immersive treatment that takes you out of your everyday environment to focus completely on sobriety.
In some programs, medication assistance may be utilized as part of the treatment process. In the case of someone who is particularly prone to alcohol abuse, certain medications may be used to curb cravings and ease the recovery process. Additionally, non-stimulant alternatives may be considered for those whose co-abuse involves drugs such as Concerta.
Therapy will address relapse prevention skills as well as aftercare planning.
In cases of both non-prescribed co-abuse of Concerta with alcohol, as well as those where Concerta was initially prescribed as part of a therapeutic regimen, individuals will receive the most effective treatment in a program specializing in multi-substance abuse and dual diagnosis conditions.
If you are not sure what kind of treatment might be right for you, call us at 1-888-744-0069 to speak with a treatment support advisor about finding the perfect recovery program for you.
Concerta abuse is increasingly common. Consider the following quotes from researchers:
- “Methylphenidate Hydrochloride (Concerta) has been reported to be the most common prescription stimulant used for non-medical purposes in a national survey.” (Kroutil et al. 2006)
- “Concerta abuse seems to be partially driven by the belief that ADHD stimulant medications allow the user to drink more alcohol, thus facilitating late-night partying.” (Godfrey 2009)
Abuse of methylphenidate (Concerta) and alcohol is alarmingly common in college students. A national study of U.S. college students found that:
- Nonmedical users of prescription stimulants were more than 6 times more likely to report frequent heavy drinking than their peers who did not use prescription stimulants.
- In 2005, more than 1 in 10 college students reported using both alcohol and stimulants.
Concurrent Alcohol and Concerta Abuse in Teens
A growing number of teens and adolescents are using prescription stimulants under the belief that it will improve academic ability. In fact, Concerta and Ritalin are often referred to as “smart” or “study” drugs, which has the implication they are less harmful when abused than they really are.
Recreational use of drugs is especially risky during adolescence because the brain is still developing.
Concerta and alcohol both exert powerful effects on the brain, especially when used at the same time, and so teens should cautiously avoid this dangerous drug combination. Recent studies have found that alcohol is consumed in larger amounts while using Concerta, than when using alcohol alone (Barkla et al., 2015).
Providing an education about these drugs and their effects, emphasizing the importance of healthy brain development, and staying engaged with your teen will help them better understand the risks associated with co-abuse. Also, it’s extremely important to emphasize that prescription drugs can be just as dangerous as illegal drugs when abused.
If you believe a teen in your life may have a stimulant and/or alcohol abuse or addiction problem, call our hotline at 1-888-744-0069 for information about finding a treatment program that will work for you and your teen.
Resources, Articles and More Information
To learn more, check out the following articles:
Also, join the conversation today by visiting our Forum.
- Biederman, J. & Spencer, T. (2002). Methylphenidate in treatment of adults with Attention-Deficit/Hyperactivity Disorder. Journal of Attentional Disorders, 6 (1), S101-S107.
- Barrett, S. P. & Pihil, R. O. (2002). Oral methylphenidate-alcohol co-abuse. Journal of Clinical Psychopharmacology, 22 (6), 633-634.
- Barkla, X.M., McArdle, P.A., and Newbury-Birch, D. (2015). Are there any potentially dangerous pharmacological effects of combining ADHD medication with alcohol and drugs of abuse. A systematic review of the literature. BMC Psychiatry, 51(1):270.
- Griffin, W.C., McGovern, R. W., Bell, G.H., Randall, P.K., Middaugh, L. D., & Patrick, K. S. (2013). Psychopharmacology, 225, 613-625.
- Godfrey, J. (2009). Safety of therapeutic methylphenidate in adults: A systemic review of the evidence. Journal of Psychopharmacology, 23 (2), 194-205.
- Kroutil, L. A., Van Brunt, D. L., Herman-Stahl, M. A., Heller, D. C., Bray, R. M., & Penne, M. A. (2006). Nonmedical use of prescription stimulants in the United States. Drug and Alcohol Dependence, 84 (2), 135-143.
- McCabe, S. E., Knight, J. R., Teter, C. J., & Wechsler, H. (2005a). Non-medical use of prescription stimulants among U.S. college students: Prevalence and correlates from a national survey. Addiction, 100, 96-106.
- McCabe, S. E., Cranforn, J. A., Morales, M., & Young, A. (2006). Simultaneous and concurrent polydrug use of alcohol and prescription drugs: Prevalence, correlates, and consequences. Journal of Studies on Alcohol, 67 (4), 529-537.
- Oscar-Berman, M., Shagrin, B., Evert, D. L., & Epstein, C. (1997). The Neurological Effects of Alcohol. Alcohol, Health and Research World, 21 (1), 65-75.
- Substance Abuse and Mental Health Services Administration. Results from the 2002 National Survey on Drug Use and Health: National Findings (NSDUH Series H-22, DHHS Publication No. SMA 03- 3836). Rockville, MD: Office of Applied Studies, 2003.
- Volkow, N., Wang, G., Fowler, J., & Ding, Y. (2005). Imaging the Effects of Methylphenidate on Brain Dopamine: New Model on Its Therapeutic Actions for Attention-Deficit/Hyperactivity Disorder. Biological Psychiatry, 57, 1410-1415.